Observational Study on the Use of Akynzeo® in Patients Receiving HEC

NCT03649230 · clinicaltrials.gov ↗

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-Induced Nausea and Vomiting

Interventions

DRUG: 300mg netupitant/0.5mg palonosetron hydrochloride

Sponsor

Purdue Pharma, Canada